1. Home
  2. ASNS vs EVOK Comparison

ASNS vs EVOK Comparison

Compare ASNS & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASNS
  • EVOK
  • Stock Information
  • Founded
  • ASNS 1998
  • EVOK 2007
  • Country
  • ASNS United States
  • EVOK United States
  • Employees
  • ASNS N/A
  • EVOK N/A
  • Industry
  • ASNS Telecommunications Equipment
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASNS Telecommunications
  • EVOK Health Care
  • Exchange
  • ASNS Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • ASNS 6.7M
  • EVOK 5.4M
  • IPO Year
  • ASNS 2022
  • EVOK 2013
  • Fundamental
  • Price
  • ASNS $0.66
  • EVOK $4.80
  • Analyst Decision
  • ASNS Strong Buy
  • EVOK
  • Analyst Count
  • ASNS 1
  • EVOK 0
  • Target Price
  • ASNS $5.00
  • EVOK N/A
  • AVG Volume (30 Days)
  • ASNS 22.9M
  • EVOK 30.9K
  • Earning Date
  • ASNS 11-13-2025
  • EVOK 11-06-2025
  • Dividend Yield
  • ASNS N/A
  • EVOK N/A
  • EPS Growth
  • ASNS N/A
  • EVOK N/A
  • EPS
  • ASNS N/A
  • EVOK N/A
  • Revenue
  • ASNS $5,265,000.00
  • EVOK $12,794,859.00
  • Revenue This Year
  • ASNS N/A
  • EVOK $57.38
  • Revenue Next Year
  • ASNS $198.35
  • EVOK $59.57
  • P/E Ratio
  • ASNS N/A
  • EVOK N/A
  • Revenue Growth
  • ASNS N/A
  • EVOK 70.02
  • 52 Week Low
  • ASNS $0.33
  • EVOK $1.94
  • 52 Week High
  • ASNS $1.78
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • ASNS 74.31
  • EVOK 43.60
  • Support Level
  • ASNS $0.33
  • EVOK $4.23
  • Resistance Level
  • ASNS $0.76
  • EVOK $4.94
  • Average True Range (ATR)
  • ASNS 0.07
  • EVOK 0.30
  • MACD
  • ASNS 0.03
  • EVOK -0.06
  • Stochastic Oscillator
  • ASNS 62.28
  • EVOK 46.36

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: